More stories
COMPASS Pathways to participate in upcoming Jefferies Healthcare Conference
LONDON, May 26, 2023 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based...
Psychedelics Weekly – New LSD Research and The Challenges Facing a Rapidly Growing Psychedelic...
In this episode of Psychedelics Weekly, Kyle and David meet up to talk news, but end up mostly having a discussion about the numerous...
Terran Biosciences announces new breakthroughs in the chemistry of MDMA and its enantiomers and...
New York, May 26, 2023 /PRNewswire/ — Terran Biosciences (“Terran”), a biotech platform company dedicated to the development of transformational therapeutics for neurological and...
Sunstone Therapies presents data at ASCO showing positive long-term follow-up results from psilocybin therapy...
Sunstone Therapies presents data at ASCO showing positive long-term follow-up results from psilocybin therapy in cancer patients with major depressive disorder (MDD) Rockville, Maryland,...
Data Demonstrating Long-Term Improvement in Depression in Cancer Patients Following Single Dose of COMP360...
LONDON, May 26, 2023 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to...
Small Pharma Announces Significant Developments In Intellectual Property Portfolio
LONDON, May 25, 2023 (GLOBE NEWSWIRE) — Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology company focused on...
Numinus Aligns Business Initiatives to Prepare for Future Approval of MDMA-Assisted Therapy
VANCOUVER, BC, May 25, 2023 /PRNewswire/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing...
PT411 – The Humanity of Healthcare Professionals, Ancient Psychedelic Use, and Breaking the Cycle...
In this episode, Joe interviews Priyanka Wali, MD: board-certified practicing physician in Internal Medicine, MAPS-trained psychedelic facilitator, comedian, and co-host (with Sean Hayes of...
Clearmind Medicine Announces First US Site for its Phase I/IIa Clinical Trial Evaluating CMND-100...
Tel Aviv, Israel / Vancouver, Canada, May 22, 2023 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the “company”),...
Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification
Tel Aviv, Israel / Vancouver, Canada, May 19, 2023 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND), (FSE: CWY) (“Clearmind” or “the...
Psychedelics Weekly – Challenging the ‘Gifting’ Part of Prop 122, Public Perception in Oregon,...
In this episode of Psychedelics Weekly, Joe and Kyle are both on the road, so David and Alexa take the helm. They cover news...
Psychedelics Today – Tales of Transformation
Join us at the Athenaeum on 6/8 before the NYC psychedelic community’s mass exodus for Denver and Psychedelic Science 2023. Psychedelics Today is presenting...
